Cargando…

A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments

Fragile X syndrome (FXS) is caused by silencing of the FMR1 gene, which encodes a protein with a critical role in synaptic plasticity. The molecular abnormality underlying FMR1 silencing, CGG repeat expansion, is well characterized; however, delineation of the pathway from DNA to RNA to protein usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Budimirovic, Dejan B., Schlageter, Annette, Filipovic-Sadic, Stela, Protic, Dragana D., Bram, Eran, Mahone, E. Mark, Nicholson, Kimberly, Culp, Kristen, Javanmardi, Kamyab, Kemppainen, Jon, Hadd, Andrew, Sharp, Kevin, Adayev, Tatyana, LaFauci, Giuseppe, Dobkin, Carl, Zhou, Lili, Brown, William Ted, Berry-Kravis, Elizabeth, Kaufmann, Walter E., Latham, Gary J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601415/ https://www.ncbi.nlm.nih.gov/pubmed/33008014 http://dx.doi.org/10.3390/brainsci10100694

Ejemplares similares

A methylation PCR method determines FMR1 activation ratios and differentiates premutation allele mosaicism in carrier siblings
por: Hadd, Andrew G., et al.
Publicado: (2016)

Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxiety
por: Klusek, Jessica, et al.
Publicado: (2017)

Development of a Quantitative FMRP Assay for Mouse Tissue Applications
por: Adayev, Tatyana, et al.
Publicado: (2021)

Fragile X Syndrome: Recent Research Updates toward Capturing Treatments’ Improvement in Clinical Trials
por: Budimirovic, Dejan B., et al.
Publicado: (2022)

Detection and Quantification of the Fragile X Mental Retardation Protein 1 (FMRP)
por: LaFauci, Giuseppe, et al.
Publicado: (2016)

Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation alleles
por: Nolin, Sarah L., et al.
Publicado: (2019)

Fragile X-Associated Disorders in Serbia: Baseline Quantitative and Qualitative Survey of Knowledge, Attitudes and Practices Among Medical Professionals
por: Budimirovic, Dejan B., et al.
Publicado: (2018)

Fragile X protein in newborn dried blood spots
por: Adayev, Tatyana, et al.
Publicado: (2014)

Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins
por: Napoli, Eleonora, et al.
Publicado: (2018)

AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission
por: Yrigollen, Carolyn M, et al.
Publicado: (2014)

Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study
por: Barad, David H., et al.
Publicado: (2017)

Activation Ratio Correlates with IQ in Female Carriers of the FMR1 Premutation
por: Protic, Dragana, et al.
Publicado: (2023)

Developmental profiles of infants with an FMR1 premutation
por: Wheeler, Anne C., et al.
Publicado: (2016)

Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders
por: Trajković, Jelena, et al.
Publicado: (2022)

Efficient Delivery of FMR1 across the Blood Brain Barrier Using AAVphp Construct in Adult FMR1 KO Mice Suggests the Feasibility of Gene Therapy for Fragile X Syndrome
por: Chadman, Kathryn K., et al.
Publicado: (2023)

Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions
por: Kim, Kyoungmi, et al.
Publicado: (2019)

Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
por: Lee, Anna W., et al.
Publicado: (2018)

A case study in citizen environmental humanities: creating a participatory plant story website
por: Gianquitto, Tina, et al.
Publicado: (2022)

Fragile X Syndrome: From Molecular Aspect to Clinical Treatment
por: Protic, Dragana D., et al.
Publicado: (2022)

Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots
por: Boggs, Anna E., et al.
Publicado: (2022)

Absence of AGG Interruptions Is a Risk Factor for Full Mutation Expansion Among Israeli FMR1 Premutation Carriers
por: Domniz, Noam, et al.
Publicado: (2018)

Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X Syndrome
por: Premoli, Marika, et al.
Publicado: (2023)

Associated features in females with an FMR1 premutation
por: Wheeler, Anne C, et al.
Publicado: (2014)

A Unique Visual Attention Profile Associated With the FMR1 Premutation
por: Winston, Molly, et al.
Publicado: (2021)

Curvilinear Association Between Language Disfluency and FMR1 CGG Repeat Size Across the Normal, Intermediate, and Premutation Range
por: Klusek, Jessica, et al.
Publicado: (2018)

Language processing skills linked to FMR1 variation: A study of gaze-language coordination during rapid automatized naming among women with the FMR1 premutation
por: Nayar, Kritika, et al.
Publicado: (2019)

Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries?
por: Protic, Dragana, et al.
Publicado: (2021)

Mortality in Women across the FMR1 CGG Repeat Range: The Neuroprotective Effect of Higher Education
por: Hong, Jinkuk, et al.
Publicado: (2023)

High performing male with fragile X syndrome with an unmethylated FMR1 full mutation: The relevance of clinical and genetic correlations
por: Shieh, Meg, et al.
Publicado: (2023)

Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation
por: Tassone, Flora, et al.
Publicado: (2023)

FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States
por: Tassone, Flora, et al.
Publicado: (2012)

Data-driven phenotype discovery of FMR1 premutation carriers in a population-based sample
por: Movaghar, Arezoo, et al.
Publicado: (2019)

Distribution of FMR1 and FMR2 Repeats in Argentinean Patients with Primary Ovarian Insufficiency
por: Espeche, Lucía Daniela, et al.
Publicado: (2017)

Is FMR1 CGG Repeat Number Polymorphism Associated With Phenotypic Variation in the General Population? Report From a Cohort of 5,499 Adults
por: Hong, Jinkuk, et al.
Publicado: (2021)

Array-Based FMR1 Sequencing and Deletion Analysis in Patients with a Fragile X Syndrome–Like Phenotype
por: Collins, Stephen C., et al.
Publicado: (2010)

Neurobehavioral anatomy
por: Filley, Christopher M., 1951-

Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)
por: Alvarez-Mora, Maria Isabel, et al.
Publicado: (2022)

Fragile X Syndrome: Lessons Learned from the Most Translated Neurodevelopmental Disorder in Clinical Trials
por: Duy, Phan Q., et al.
Publicado: (2017)

Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study
por: Budimirovic, Dejan B., et al.
Publicado: (2021)

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
por: Budimirovic, Dejan B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ap9kpi81eo4b1odk0m67qphjmj